期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Expression and Prognostic Significance of Livin in the Progression of Bladder Cancer 被引量:3
1
作者 朱朝辉 王艳波 +2 位作者 丁小博 曾甫清 徐凯 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2008年第1期90-92,共3页
It has been suggested that progression of bladder transitional cell cancer (BTCC) may be regulated at the molecular level by a typical pattern of expression of genes involved in apoptosis. Recently Livin, belonging ... It has been suggested that progression of bladder transitional cell cancer (BTCC) may be regulated at the molecular level by a typical pattern of expression of genes involved in apoptosis. Recently Livin, belonging to the inhibitors of apoptosis (IAP) family, has been found to be expressed in most solid tumors, where its expression is suggested to have clinical significance. In order to explore the significance of Livin expression in the development of BTCC, immunohistochemistry and RT-QPCR were used to detect the expression of Livin mRNA in tumor tissues and adjacent normal tissues of 30 cases of BTCC. The results showed that the positive rate of Livin expression in adjacent normal tissues and tumor tissues was 0 and 60% (18/30) respectively. The -△△CT value of Livin in BTCC tissues was 8.0454 (7.4264-8.6644) times of that in adjacent normal tissues. The expression of Livin mRNA had no correlation with tumor pathological grades and clinical stages. It was suggested that there was weak expression of Livin mRNA in adjacent normal tissues, but strong in tumor tissues. 展开更多
关键词 LIVIN bladder cancer real-time quantitative PCR immunohistochemistry
下载PDF
Survivin在膀胱移行细胞癌中的表达及其临床意义 被引量:5
2
作者 王艳波 朱朝辉 +3 位作者 曾甫清 丁小博 徐凯 张景辉 《临床泌尿外科杂志》 2007年第4期292-295,共4页
目的:检测抗凋亡(IAP)家族中生存素(Survivin)基因在膀胱移形细胞癌(BTCC)组织及癌旁组织的表达,探讨Survivin的表达在膀胱癌发生发展中的意义。方法:采用免疫组织化学和实时荧光定量逆转录聚合酶链反应(RT-QPCR)方法,对30例BTCC患者中S... 目的:检测抗凋亡(IAP)家族中生存素(Survivin)基因在膀胱移形细胞癌(BTCC)组织及癌旁组织的表达,探讨Survivin的表达在膀胱癌发生发展中的意义。方法:采用免疫组织化学和实时荧光定量逆转录聚合酶链反应(RT-QPCR)方法,对30例BTCC患者中Survivin基因在癌组织和癌旁组织中的表达进行检测。结果:免疫染色标本中,在癌旁组织、BTCC和胚胎癌组织中Survivin的阳性表达率分别为0、60%和100%。同一患者,Survivin在BTCC的表达量远大于癌旁组织,Survivin在BTCC组织中的-ΔΔCT值是癌旁组织的10.2829(9.0034~11.5624)倍,同时在病理分级之间和临床分期之间均有统计学意义(P<0.05)。结论:Survivin基因在癌旁组织中有少量表达,而在BTCC组织中的表达量远远高于癌旁组织;其表达量与病理分级和临床分期均有相关性。 展开更多
关键词 Survivin(生存素) 膀胱肿瘤 实时荧光定量PCR 免疫组化
下载PDF
Argonaute-2蛋白在膀胱移行上皮癌组织中的表达及其临床意义 被引量:1
3
作者 李军 李伟 +4 位作者 杨丰强 鄢阳 车建平 刘敏 郑军华 《现代泌尿外科杂志》 CAS 2015年第2期118-122,共5页
目的研究Argonaute-2蛋白在膀胱移行上皮癌组织中的表达及临床意义。方法通过实时荧光定量PCR、免疫组化法测定88例经病理确诊的膀胱移行上皮癌患者配对的肿瘤组织、癌旁组织中Argonaute-2蛋白的表达,分析该蛋白表达与预后和其他临床病... 目的研究Argonaute-2蛋白在膀胱移行上皮癌组织中的表达及临床意义。方法通过实时荧光定量PCR、免疫组化法测定88例经病理确诊的膀胱移行上皮癌患者配对的肿瘤组织、癌旁组织中Argonaute-2蛋白的表达,分析该蛋白表达与预后和其他临床病理参数的相关性。结果膀胱移行上皮癌组织中Argonaute-2 mRNA表达明显高于癌旁组织(P<0.05);Argonaute-2蛋白表达明显高于癌旁组织(P<0.05)。高表达Argonaute-2与肿瘤的病理分级、临床分期以及淋巴结转移情况显著相关。利用Kaplan-Meier生存曲线和Log-Rank检验分析显示,肿瘤组织中Argonaute-2蛋白高表达组患者的5年生存率较低表达组患者明显降低(62.2%vs.86.3%,P<0.05)。结论 Argonaute-2蛋白的异常表达可能参与膀胱移行上皮癌的发生、发展,可作为膀胱癌预后评估的一个重要生物学指标。 展开更多
关键词 膀胱癌 Argonaute-2蛋白 实时荧光定量PCR 免疫组织化学法
下载PDF
The association of altered RARβ gene expression with the cervical lesion pathogenesis 被引量:1
4
作者 Nafeisha Kadeer Hui He +2 位作者 Abida Abudoukadeer Anaguli Ababaikeli Abulizi Abudula 《The Chinese-German Journal of Clinical Oncology》 CAS 2011年第9期526-530,共5页
Objective:Previous reports have shown that the gene promoter region of retinoic acid receptor β(RARβ) was hypermethylated in cervical carcinoma,implying the inhibition of gene transcription.The aim of this study was... Objective:Previous reports have shown that the gene promoter region of retinoic acid receptor β(RARβ) was hypermethylated in cervical carcinoma,implying the inhibition of gene transcription.The aim of this study was to investigate the association of cervical cancer development with the RARβ gene expression at the mRNA and protein level to assess the impact of RARβ as a marker for early detection of the cancer.Methods:We collected 126 cases of formalin fixed and paraffin embedded cervical tissue specimens as well as 37 cases of fresh tissue samples from women with cervicitis,cervical intraepithelial neoplasia(CIN) and cervical squamous cell carcinoma(CSCC).The RARβ mRNA and protein expression was detected by quantitative RT-PCR and immunohistochemistry,respectively.Results:(1) The mRNA expression of RARβ in CIN and cervical cancer was markedly decreased compared to cervicitis with a statistically very significant difference,but no difference was found between CIN and cervical cancer.(2) RARβ protein was normally expressed in the epithelial cells of cervicitis and partially lost in a few cases,but with the development of cervical lesion pathogenesis and cancer,a significant loss of protein expression was detected in CIN(38%) and CSCC(57%) compared to cervicitis(P < 0.01).Conclusion:The downregulation of RARβ transcription or loss of protein expression is an important indicator of cervical cancer and its precursur lesions.The detection of RARβ expression coupled with aberrant methylation of the gene may become a biomarker for the early prognosis or diagnosis of the cancer. 展开更多
关键词 RARβ cervical cancer quantitative rt-pcr immunohistochemistry
下载PDF
PAK6在膀胱癌中表达及其临床意义 被引量:7
5
作者 乾孝园 董丰铭 +1 位作者 李伟 刘屹立 《中华实用诊断与治疗杂志》 2018年第12期1193-1196,共4页
目的探讨p21活化激酶6(p21一activated kinase 6,PAK6)在膀胱癌中的表达情况及其临床意义。方法膀胱癌患者89例(膀胱癌组),取其膀胱癌组织;行膀胱部分切除或全部切除术患者30例为对照组,取其正常膀胱上皮组织。采用免疫组织化学法检测2... 目的探讨p21活化激酶6(p21一activated kinase 6,PAK6)在膀胱癌中的表达情况及其临床意义。方法膀胱癌患者89例(膀胱癌组),取其膀胱癌组织;行膀胱部分切除或全部切除术患者30例为对照组,取其正常膀胱上皮组织。采用免疫组织化学法检测2组组织PAK6蛋白阳性表达率。Biu-87、T24膀胱癌细胞和SV-HUC-1正常膀胱细胞分为Biub一87组、T24组和SV-HUC-1组,采用实时荧光定量PCR法检测3组细胞PAK6mRNA表达水平,采用Westernblot法检测3组细胞PAK6蛋白表达水平。结果膀胱癌组PAK6蛋白阳性表达率(46.07%)明显低于对照组(96.67%)(P<O.05),膀胱癌组复发者PAK6蛋白阳性表达率(29.41%)低于原发者(56.36%)(P<O.05),膀胱癌组PAK6蛋白阳性表达率在肿瘤数量、病理分级、是否转移和临床分期上差异无统计学意义(P>O.05);Biu一87组和T24组细胞PAK6mRNA(0.0189±0.0037、0.053O±0.0129)和PAK6蛋白表达水平(O.0993±0.0121、0.1431±0.0081)明显低于SV-HUC-1组(1.0403±0.3755、0.3381±0.0511),Biu-87组低于T24组(P<O.05)。结论PAK6在膀胱癌组织及细胞中呈低表达,且与膀胱癌的复发密切相关,可能在膀胱癌的发生、发展中起抑制作用,可作为新的抑癌指标指导临床。 展开更多
关键词 膀胱癌 p21活化激酶6 免疫组织化学法 实时荧光定量PCR法 WESTERN BLOT法 复发
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部